| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/21/1993 | EP0466730B1 Geminal bisphosphonic acids and derivatives as anti-arthritic agents |
| 07/21/1993 | EP0420875B1 Fine-milled colestipol hydrochloride |
| 07/21/1993 | CN1074479A Process for the preparation of organic germanium (Ge-132) beer |
| 07/21/1993 | CN1074447A Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation |
| 07/21/1993 | CN1074446A Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation |
| 07/21/1993 | CN1074444A New thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 07/21/1993 | CN1074438A Antithrombotic agents |
| 07/21/1993 | CN1074437A Narrow poly-and mono-dispersed anionic oligomers, and their uses, formulations and process |
| 07/21/1993 | CN1074372A Preparation of gynostemma-pentaphylla prednisone |
| 07/21/1993 | CN1074371A Ascorbic-acid styptic powder |
| 07/21/1993 | CN1074370A Composition for accelerating wound healing |
| 07/21/1993 | CN1074369A Pharmaceutical composition for inhibiting the infection with aids virus |
| 07/21/1993 | CN1074368A A controlled release drug dispersion delivery device |
| 07/21/1993 | CN1021654C Esters of hexahydro-8-hydroxy-2,6-methylene-2H-quinolizin-3(4H)-one and related compounds |
| 07/21/1993 | CN1021652C Substitutes N-(1-alkyl-3-hydroxy-4-piperidinyl) benzamides |
| 07/21/1993 | CN1021632C Pharmaceutical composition comprising an organic zinc complex and a process for preparing the active substance |
| 07/21/1993 | CN1021631C Preparation of antipsychotic fused-ring pyridinypiperazine derivatives |
| 07/21/1993 | CN1021630C Use of phenethanol amines to improve fat content of sows' milk |
| 07/21/1993 | CN1021629C Medicine compound of non-suspending agent and stable sucralfate suspending liquid |
| 07/20/1993 | US5229510 Enzyme inhibitors |
| 07/20/1993 | US5229505 CNS and cardiovascular effects |
| 07/20/1993 | US5229423 Use of butylurea as a contraceptive agent |
| 07/20/1993 | US5229421 Methods and compositions for inhibiting lipoxygenase |
| 07/20/1993 | US5229418 Histamine H-2 receptor antagonists, antiulcer |
| 07/20/1993 | US5229417 2-(3-phenylpropyl)hydrazines and method of treating personality disorders |
| 07/20/1993 | US5229416 Parasiticide, insecticide, antihelmintic |
| 07/20/1993 | US5229415 Alkylthio alkyl avermectins are active antiparasitic agents |
| 07/20/1993 | US5229413 Nervous system disorders |
| 07/20/1993 | US5229412 Administering carrier with anxiolytic derivatives of N-(3-/4-indolyloxy/-2-hydroxypropyl)-1,8-diamino-p-menthane |
| 07/20/1993 | US5229410 Antidepressant, tranquilizers |
| 07/20/1993 | US5229409 6-substituted-tetrahydrobenz[cd]indoles |
| 07/20/1993 | US5229407 Medicaments |
| 07/20/1993 | US5229405 Rheumatic diseases |
| 07/20/1993 | US5229403 Enzyme inhibitors, antiinflammatory |
| 07/20/1993 | US5229399 Analgesics |
| 07/20/1993 | US5229394 Dextromethorphan |
| 07/20/1993 | US5229392 2-aminopyrimidine-4-carboxamide derivatives, their preparaton and their application in therapy |
| 07/20/1993 | US5229390 Beverage |
| 07/20/1993 | US5229389 Method for evaluating neuronal activity of a drug |
| 07/20/1993 | US5229388 3-[4-(1-substituted-4-piperazinyl)butyl]-4-thiazolidinone and related compounds |
| 07/20/1993 | US5229381 Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 07/20/1993 | US5229380 Method for treating helicobacter pylori gastritis |
| 07/20/1993 | US5229379 Certain n-substituted-amino-alkane phosphinic acid derivatives having anti-epileptic properties |
| 07/20/1993 | US5229378 Antioxidant, antiinflammatory, antiallergen |
| 07/20/1993 | US5229376 Encapsulated plant-derived phosphatidylinositol (PI) compositions for the prevention of mitogenically induced cell proliferation |
| 07/20/1993 | US5229375 Antitumor agents, antigrowth agents and DNA cleaving property |
| 07/20/1993 | US5229374 Method for treatment of lower gastrointestinal tract disorders |
| 07/20/1993 | US5229373 Reduction of neurotoxic effects caused by chemotherapy |
| 07/20/1993 | US5229147 Coated vitamin c preparation for animal feed, production and use thereof |
| 07/20/1993 | US5229136 Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients |
| 07/20/1993 | US5229135 Core with multilayer coating; controlling release, absorption |
| 07/20/1993 | US5229134 Pharmaceutical compositions |
| 07/20/1993 | US5229132 Non-absorbable gastrointestinal medicament provided for treating the two levels of the digestive tract at the same time |
| 07/20/1993 | US5229129 Transdermal administration of lisuride |
| 07/20/1993 | US5229123 Antifungal agents |
| 07/20/1993 | US5229116 Administering a flavonoid or hypotensive |
| 07/20/1993 | US5229108 Pharmaceutical dosage forms |
| 07/20/1993 | EP0559825A4 Method and device for treating tobacco addiction. |
| 07/20/1993 | CA1320503C Process for the production of polyfluorinated ethers |
| 07/20/1993 | CA1320498C2 Methods and compositions for inhibiting lipoxygenase |
| 07/20/1993 | CA1320495C2 Optically active ketals, processes for their preparation and their use in the synthesis of alpha-arylakanoic acids |
| 07/20/1993 | CA1320493C Substituted thieno (2,3-.beta.) thiophene-2-sulfonamides as antiglauc oma agents |
| 07/20/1993 | CA1320492C Process for the preparation of novel 2-thienyl-oxyacetic acid derivatives |
| 07/20/1993 | CA1320491C Thiadiazole guanidines |
| 07/20/1993 | CA1320490C Anti-inflammatory agents |
| 07/20/1993 | CA1320487C Substituted thieno[2,3-.beta.]thiophene-2-sulfonamides as antiglaucoma agents |
| 07/20/1993 | CA1320486C .alpha. -adrenergic receptor antagonists |
| 07/20/1993 | CA1320485C .alpha. -adrenergic receptor antagonists |
| 07/20/1993 | CA1320449C Methods and compositions for thrombolytic therapy |
| 07/20/1993 | CA1320448C Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
| 07/20/1993 | CA1320447C Antidiabetic composition comprising isocarbacyclin derivative |
| 07/20/1993 | CA1320445C Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same |
| 07/20/1993 | CA1320444C Pharmaceutical preparations containing iodine having a low water content |
| 07/20/1993 | CA1320443C Liposomal vesicles for intraperitoneal administration of therapeutic agents |
| 07/20/1993 | CA1320442C Impotence ointment |
| 07/20/1993 | CA1320441C Use of growth hormone for nitrogen retention under hypocaloric conditions |
| 07/20/1993 | CA1320440C Natural pulmonary surfactant, method of preparation and pharmaceutical compositions |
| 07/18/1993 | CA2087147A1 Method for administration of azauridine for the treatment of rheumatoid arthritis |
| 07/17/1993 | CA2087112A1 Imidazole derivatives having anti-hiv activity |
| 07/16/1993 | WO1993014096A1 Phosphono derivatives of amino acids as metalloproteinase inhibitors |
| 07/16/1993 | CA2105309A1 Phosphono derivatives of amino acids as metalloproteinase inhibitors |
| 07/15/1993 | EP0559647A4 Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase. |
| 07/15/1993 | DE4231682A1 Reversible inhibiting thromboxane A2 blocker utilisation for activity inhibition - by prolonging function and storage stability of thrombocytes in thrombocyte concentrates or preserved blood, for inhibiting aggregation and treating thrombosis |
| 07/15/1993 | DE4200610A1 Verwendung von paf-antagonisten zur behandlung der dysmenorrhea Use of PAF-antagonists for the treatment of dysmenorrhea |
| 07/15/1993 | DE4200414A1 New quinoline and naphthyridinone-carboxylic acid derivs. |
| 07/15/1993 | CA2087245A1 Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use |
| 07/15/1993 | CA2087209A1 Method for treating malignant tumors with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof |
| 07/14/1993 | EP0557290A4 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss. |
| 07/14/1993 | EP0551230A1 Cyano-2-hydroxy-3-enamide derivatives, process for their preparation, their use as drugs, pharmaceutical compositions containing them and intermediates obtained |
| 07/14/1993 | EP0551219A1 Pyridylsulfonylurea, processes for their preparation and pharmaceutical compositions containing them |
| 07/14/1993 | EP0551200A1 Protein phosphatase inhibitors for use in therapy |
| 07/14/1993 | EP0551182A1 Method of treating hyperproliferative vascular disease using rapamycin, eventually in combination with mycophenolic acid |
| 07/14/1993 | EP0551180A1 Use of bucillamine for the manufacture of a medicament for the treatment of cystinuria |
| 07/14/1993 | EP0551077A2 Pharmaceutical composition comprising atrial nutriuretic peptide for treatment of adult respiratory distress syndrome |
| 07/14/1993 | EP0551034A2 Cephalosporins having in position 7 a benzyloxyimino radical substitute, process for their preparation and their use as medicaments |
| 07/14/1993 | EP0550924A1 2-Pyrrolidinone derivatives as HIV protease inhibitors |
| 07/14/1993 | EP0550921A1 Pharmaceutical composition for ophthalmic use comprising a nonsteroidal anti-inflammatory and a decongestant drug |
| 07/14/1993 | EP0550903A1 Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents |
| 07/14/1993 | EP0550899A1 Process for preparing derivatives of (R) 5-pentylamino-5-oxopentanoic acid with anticholecystokinin activity |
| 07/14/1993 | EP0550895A1 4,13-dioxabicyclo (8.2.1) tridecenon-derivatives, method and intermediates for their preparation, and medicaments containing the same |